Title	Response Rate
Number of Patients Screened	9
Number of Patients Enrolled	4
Number of Patients Evaluable for Toxicity	4
Number of Patients Evaluated for Efficacy	4
Evaluation Method	IMWG Response Criteria
Response Assessment SD	n = 2 (50%)
Response Assessment PD	n = 1 (25%)
Response Assessment OTHER	n = 1 (25%)
(Median) Duration Assessments PFS	5.3 months, CI: 2.5–7.1
Waterfall plot (Figure 2 )	Waterfall plot of best percent change in M‐protein values and IMWG response. One patient had disease progression; two had stable disease, and one had a minimal response, based on M‐protein. There were no partial responses.
Outcome Notes	The 2014 IMWG response criteria for multiple myeloma were used.